A

Axsome Therapeutics

Biopharmaceutical company developing CNS disorder therapies

Manager/Senior Manager - Statistical Programming

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
Full-timeNew York, NY, USA

About the Job

Requirements

  • A bachelor's degree (BA or BS) in Computer Science, Mathematics, Statistics, Engineering, Life Science, or a related discipline is required.
  • Manager-level candidates must have at least five years of SAS programming and/or data analysis experience in the pharmaceutical or biotechnology industry, or at a Contract Research Organization.
  • Senior Manager-level candidates must have at least eight years of SAS programming and/or data analysis experience in the pharmaceutical or biotechnology industry, or at a Contract Research Organization.
  • Subject matter expertise in CDISC data standards and proven experience working with CDISC-compliant data are required.
  • At least two years of SDTM and ADaM lead experience are required.
  • Demonstrated experience developing and validating eSubmission data package components for regulatory submissions, amendments, and supplements is required.
  • The candidate must be able to work on-site Monday, Tuesday, and Thursday; fully remote candidates are not considered.
  • The candidate must be able to oversee and manage a CRO’s CDISC and ADaM dataset-related activities and Table/Figure/Listing programming activities for assigned clinical trials.
  • The candidate must be able to handle multiple tasks with competing priorities and manage time and resources to meet deadlines.
  • The candidate must be able to communicate effectively with internal and external stakeholders who may lack familiarity with programming applications in drug development and study outcomes.
  • Strong communication and presentation skills are required.

Responsibilities

  • Serve as lead study programmer on one or more clinical trials.
  • Collaborate with Biostatistics and Data Management to ensure the accuracy and reliability of reported results.
  • Develop, validate, and execute SAS programs and macros to generate SDTM and ADaM datasets and presentation-ready TFL outputs defined in the SAP for the CSR and regulatory submissions.
  • Manage CRO partners to ensure delivery of datasets and TFL outputs according to project timelines.
  • Develop programming specifications and programming quality check plans, and provide input on study-related documents such as the SAP, TFL specifications, Case Report Forms, Data Management Plans, and Data Transfer Specifications.
  • Lead eSubmission data package planning, execution, and quality checks of eCRT package components, including the Study Data Reviewer’s Guide, Analysis Reviewer’s Guide, define.xml, and Study Data Standardization Plan.
  • Provide hands-on programming as needed, perform ad hoc analyses, and respond promptly to inquiries from regulatory authorities.
  • Maintain code, logs, and outputs consistently within a regulated environment.
  • Contribute to developing Standard Operating Procedures, Work Instructions, and templates within the function.
  • Ensure knowledge transfer during and at the completion of studies and projects.
  • Stay current with changes in the programming field and implement new ideas and advanced processes where applicable.

Desired Qualifications

  • SAS certification is highly preferred.
  • R or Python programming skills are desirable.
  • Flexibility in approach while ensuring delivery of high-quality work in a dynamic environment.

About the Company

Axsome Therapeutics

Biopharmaceutical company developing CNS disorder therapies

Axsome Therapeutics develops therapies for central nervous system disorders. Its focus is on research, development, and commercialization of treatments for conditions such as major depressive disorder, treatment-resistant depression, Alzheimer's agitation, migraine, narcolepsy, fibromyalgia, and smoking cessation. The flagship product candidate, AXS-05, is an oral NMDA receptor antagonist intended to treat MDD and TRD; it works by blocking NMDA receptors to influence brain signaling involved in mood and depression, and has received FDA Breakthrough Therapy Designation. The company earns revenue from the commercialization of its drugs, partnerships, and potential licensing deals as its pipeline progresses through clinical trials and regulatory approvals. Axsome aims to provide effective CNS therapies, advance its drug pipeline, and improve patient outcomes and quality of life.

Company size
501-1,000
Company stage
IPO
Headquarters
New York City, New York
Founded
2012

Recently Posted Jobs

Explore more opportunities at Axsome Therapeutics

See more jobs